KEQU KEWAUNEE SCIENTIFIC CORP revenue, earnings and financials
For the quarter ended July 31, 2026, KEWAUNEE SCIENTIFIC CORP reported revenue of $66.3M (down 6.7% from a year earlier), net income of $1.71M and diluted EPS of $0.58; over the last four quarters revenue was $277M and net income $8.23M; for the fiscal year ended April 2026 revenue was $282M, up 17.3% on the year before.
KEQU annual revenue and earnings
- Fiscal year ended Apr 2026: revenue $282M, gross profit $80.4M, operating income $16.7M, net income $9.62M (margin 3.4%), EPS $3.22
- Fiscal year ended Apr 2025: revenue $240M, gross profit $68.9M, operating income $17.8M, net income $11.4M (margin 4.7%), EPS $3.83
- Fiscal year ended Apr 2024: revenue $204M, gross profit $52.1M, operating income $18.3M, net income $18.8M (margin 9.2%), EPS $6.38
- Fiscal year ended Apr 2023: revenue $219M, gross profit $35.6M, operating income $5.36M, net income $738K (margin 0.3%), EPS $0.25
- Fiscal year ended Apr 2022: revenue $169M, gross profit $24.2M, operating income −$2.61M, net income −$6.13M (margin -3.6%), EPS −$2.20
KEQU quarterly revenue and earnings
- Quarter ended Jul 31, 2026: revenue $66.3M (down 6.7% year over year), net income $1.71M, EPS $0.58
- Quarter ended Apr 30, 2026 (from the annual report): revenue $71.4M (down 7.5% year over year), net income $3.39M, EPS $1.13
- Quarter ended Jan 31, 2026: revenue $69.4M (up 3.3% year over year), net income $692K, EPS $0.23
- Quarter ended Oct 31, 2025: revenue $70.1M (up 46.8% year over year), net income $2.45M, EPS $0.82
- Quarter ended Jul 31, 2025: revenue $71.1M (up 46.9% year over year), net income $3.09M, EPS $1.04
- Quarter ended Apr 30, 2025 (from the annual report): revenue $77.1M (up 36.1% year over year), net income $4.85M, EPS $1.63
- Quarter ended Jan 31, 2025: revenue $67.2M (up 43.6% year over year), net income $1.35M, EPS $0.45
- Quarter ended Oct 31, 2024: revenue $47.8M (down 5.3% year over year), net income $3.01M, EPS $1.01
- Quarter ended Jul 31, 2024: revenue $48.4M (down 2.9% year over year), net income $2.19M, EPS $0.74
- Quarter ended Apr 30, 2024 (from the annual report): revenue $56.7M (up 5.0% year over year), net income $11.0M, EPS $3.74
- Quarter ended Jan 31, 2024: revenue $46.8M (down 23.1% year over year), net income $2.52M, EPS $0.85
- Quarter ended Oct 31, 2023: revenue $50.4M (down 7.6% year over year), net income $2.73M, EPS $0.93
- Quarter ended Jul 31, 2023: revenue $49.8M (down 0.6% year over year), net income $2.47M, EPS $0.86
- Quarter ended Apr 30, 2023 (from the annual report): revenue $54.0M (up 8.6% year over year), net income $1.01M, EPS $0.36
- Quarter ended Jan 31, 2023: revenue $60.8M (up 49.7% year over year), net income $723K, EPS $0.25
- Quarter ended Oct 31, 2022: revenue $54.6M (up 39.8% year over year), net income −$243K, EPS −$0.09
- Quarter ended Jul 31, 2022: revenue $50.1M (up 26.9% year over year), net income −$747K, EPS −$0.27
- Quarter ended Apr 30, 2022: revenue $49.7M (up 28.4% year over year), net income −$362K, EPS −$0.13
- Quarter ended Jan 31, 2022: revenue $40.6M, net income −$1.32M, EPS −$0.47
- Quarter ended Oct 31, 2021: revenue $39.0M, net income −$3.10M, EPS −$1.11
KEQU cash flow, buybacks and dividends
- Fiscal year ended Apr 2026: operating cash flow $18.6M, share buybacks $0
- Fiscal year ended Apr 2025: operating cash flow $14.8M, share buybacks $1.60M
- Fiscal year ended Apr 2024: operating cash flow $19.6M, share buybacks $2.00M
- Fiscal year ended Apr 2023: operating cash flow −$3.79M, share buybacks $0
- Fiscal year ended Apr 2022: operating cash flow −$7.89M, share buybacks n/a
KEQU balance sheet
- Jul 31, 2026: cash $8.25M, total assets $176M, total liabilities $98.6M, shareholders' equity $75.0M, long-term debt $13.8M
- Apr 30, 2026: cash $9.95M, total assets $178M, total liabilities $101M, shareholders' equity $74.7M, long-term debt $15.1M
- Jan 31, 2026: cash $8.15M, total assets $176M, total liabilities $103M, shareholders' equity $70.7M, long-term debt $16.3M
- Oct 31, 2025: cash $12.6M, total assets $189M, total liabilities $117M, shareholders' equity $69.9M, long-term debt $32.3M
- Jul 31, 2025: cash $19.5M, total assets $193M, total liabilities $125M, shareholders' equity $67.1M, long-term debt $34.4M
- Apr 30, 2025: cash $14.9M, total assets $195M, total liabilities $128M, shareholders' equity $64.5M, long-term debt $34.7M
- Jan 31, 2025: cash $9.45M, total assets $189M, total liabilities $127M, shareholders' equity $60.8M, long-term debt $35.0M
- Oct 31, 2024: cash $26.0M, total assets $134M, total liabilities $73.8M, shareholders' equity $59.3M
What is KEQU's revenue?
KEWAUNEE SCIENTIFIC CORP reported $277M of revenue over its last four quarters, through July 31, 2026.
Is KEQU profitable?
Yes. KEWAUNEE SCIENTIFIC CORP earned $8.23M over the last four quarters.
What is KEQU's EPS?
Diluted earnings per share over the last four quarters were $2.76; $0.58 in the latest quarter.